Cooper Companies (NASDAQ:COO) Price Target Lowered to $85.00 at Stifel Nicolaus

Cooper Companies (NASDAQ:COO) had its target price decreased by equities researchers at Stifel Nicolaus from $95.00 to $85.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the medical device company’s stock. Stifel Nicolaus’ price target suggests a potential upside of 27.45% from the company’s previous close.

Other analysts also recently issued research reports about the stock. Robert W. Baird reduced their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research report on Wednesday, March 4th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the stock an “overweight” rating in a research note on Monday. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, Needham & Company LLC decreased their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $83.14.

Cooper Companies Stock Up 7.5%

Shares of Cooper Companies stock traded up $4.67 during trading on Friday, hitting $66.69. 1,938,826 shares of the stock were exchanged, compared to its average volume of 2,219,373. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The firm’s 50-day moving average price is $65.17 and its 200 day moving average price is $74.57. The stock has a market cap of $13.01 billion, a price-to-earnings ratio of 33.01, a price-to-earnings-growth ratio of 1.56 and a beta of 0.87. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the business earned $0.96 EPS. Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, analysts forecast that Cooper Companies will post 4.62 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Cooper Companies by 48.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares during the period. First Trust Advisors LP grew its holdings in shares of Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after buying an additional 73,165 shares during the last quarter. Cresset Asset Management LLC purchased a new position in shares of Cooper Companies during the second quarter worth about $291,000. Cerity Partners LLC increased its position in Cooper Companies by 4.4% in the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after acquiring an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. increased its position in Cooper Companies by 2.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after acquiring an additional 973 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.